Skip to main content

Articles By Jack Cush, MD

hidradenitis.jpg

Inflammatory Arthritis and Hidradenitis Suppurativa

09 December 2022

Hidradenitis suppurativa (HS) (also called acne inversa), is a chronic inflammatory skin disorder affecting apocrine gland-bearing skin in the axillae, groin, and under the breasts and is characterised by persistent or recurrent

Read Article
RheumNow Podcast square

Biosimilar Bonanza in 2023 (12.9.2022)

09 December 2022

Dr. Jack Cush reviews more than a dozen news and journal articles from this past week on RheumNow.com. 

Read Article
Video computer laptop call telehealth telemedicine

Telemedicine Updates

08 December 2022

Several recent articles inform us of recent trends in Telemedicine.

Read Article
us-capitol-477987_640.jpg

ACR Urges Congress to Prioritize Medicare Pay Cuts, Prior Authorization, and Telehealth

08 December 2022

As the legislative session comes to a close, the American College of Rheumatology (ACR) is calling on members of Congress to include the Improving Seniors’ Timely Access to Care Act (H.R. 3173/S. 3018), the Supporting Medicare Providers Act of 2022 (H.R.

Read Article
PSA068.jpg

Bimekizumab Efficacy in TNF-Refractory Psoriatic Arthritis

07 December 2022

Bimekizumab, a selective inhibitor of interleukin (IL)-17F and IL-17, has shown superior efficacy and safety in a 16 week trial in patients with active psoriatic arthritis who previously failed therapy with tumour necrosis factor-α (TNFi) inhibitors.

Read Article
PSA2L.jpg

The Top 10 Research Priorities in Psoriatic Arthritis

06 December 2022

A survey of 317 carers and clinicians focused on psoriatic arthritis has set an agenda of the top 10 research questions for psoriatic arthritis (PsA).

Read Article
genes_0.jpg

Multi-ancestry analysis reveals novel genetic loci associated with Osteoarthritis

06 December 2022

The first large multi-ancestry genetics study of osteoarthritis (OA) has found 10 novel OA-associated genetic loci, and results showed some of the OA-associated regions are robustly found in every population ancestry studied. 

Read Article
cardiac2.jpg (keep)

TARGET Trial - Cardiovascular Risk Reduction in Rheumatoid Arthritis

05 December 2022

A recent randomised clinical trial suggests immunomodulators reduce arterial inflammation, and thereby cardiovascular (CV) risk, but shows no significant benefit to TNF inhibitors over triple therapy in patients with rheumatoid arthritis (RA).

Read Article
cost.price_.biologic.injectable.jpg

Comparing Biosimilar Growth in the US, Germany, and Switzerland

05 December 2022

The biosimilar landscape will change dramatically in 2023, following the successful rollouts in other countries in Europe.

Read Article
pregnancy,embryo,fetal

Lupus Linked With Greater Risk of Cardiovascular Complications of Childbirth

02 December 2022

Pregnant women with systemic lupus erythematosus (SLE) were more prone to cardiovascular complications during delivery, and their risk seems to have increased over the past 15 years, according to national administrative data.

Read Article
×